EMEA-001082-PIP02-11-M02

Key facts

Invented name
Holoclar
Active substance
Ex-vivo expanded human autologous epithelium containing stem cells
Therapeutic area
Ophthalmology
Decision number
P/0370/2018
PIP number
EMEA-001082-PIP02-11-M02
Pharmaceutical form(s)
Living tissue equivalent
Condition(s) / indication(s)
Treatment of limbal stem cell deficiency due to ocular burns
Route(s) of administration
Ophthalmic use
Contact for public enquiries
Chiesi Farmaceutici S.p.A.

E-mail: m.toschi@chiesi.com
Tel. +39 5211 689124

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating